Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons

British Journal of Pharmacology

Volumn 142, Issue 2, 2004, Pages 257-266

  Price, Theodore J ^a,b   Patwardhan, Amol ^a   Akopian, Armen N ^b   Hargreaves, Kenneth M ^a,b   Flores, Christopher M ^a,b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Calcitonin gene related peptide; Cannabinoid; Pain; Sensory neurons; Trigeminal ganglion; Vanilloid

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID; CANNABINOID RECEPTOR; CAPSAZEPINE; CATION CHANNEL; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; ISOPROTEIN; NEUROPEPTIDE; POTASSIUM ION; PROSTAGLANDIN E2; RUTHENIUM RED; VANILLOID RECEPTOR 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENANTIOMER; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; RAT; SENSORY NERVE CELL; STATISTICAL SIGNIFICANCE; STEREOCHEMISTRY; TRIGEMINUS GANGLION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHOLINES; NAPHTHALENES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; TRIGEMINAL NERVE;

EID: 2942605741     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705778     Document Type: Article

References (61)

1. AHLUWALIA, J., URBAN, L., CAPOGNA, M., BEVAN, S. & NAGY, I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688.
2. ANCELLIN, N. & HLA, T. (1999). Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem., 274, 18997-19002.
3. BERDYSHEV, E., BOICHOT, E., CORBEL, M., GERMAIN, N. & LAGENTE, V. (1998). Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci., 63, PL125-PL129.
4. BERDYSHEV, E.V. (2000). Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 108, 169-190.
5. BEREITER, D.A., BEREITER, D.F. & HIRATA. H. (2002), Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat. Pain, 99, 547-556.
6. BERG, K.A., CLARKE, W.P., SAILSTAD, C., SALTZMAN, A. & MAAYANI, S. (1994). Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol., 46, 477-484.
7. BRIDGES, D., RICE, A.S., EGERTOVA, M., ELPHICK, M.R., WINTER, J. & MICHAEL, G.J. (2003). Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistty. Neuroscience, 119, 803-812.
8. CAMPBELL, J.N., RAJA, S.N., MEYER, R.A. & MACKINNON, S.E. (1988). Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain, 32, 89-94.
9. CARLISLE, S.J., MARCIANO-CABRAL, F., STAAB, A., LUDWICK, C. & CABRAL, G.A. (2002). Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol., 2, 69-82.
10. CHU, C.J., HUANG, S.M., DE PETROCELLIS, L., BISOGNO, T., EWING, S.A., MILLER, J.D., ZIPKIN, R.E., DADDARIO, N., APPENDINO, G., DI MARZO, V. & WALKER, J.M. (2003). N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem., 278, 13633-13639.
11. CROXFORD, J.L. & MILLER, S.D. (2003). Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R + WIN55,212. J. Clin. Invest., 111, 1231-1240.
12. CUNHA, F.Q. & FERREIRA, S.H. (2003). Peripheral hyperalgesic cytokines. Adv. Exp. Med. Biol., 521, 22-39.
13. DENDA, M., FUZIWARA, S., INOUE, K., DENDA, S., AKAMATSU, H., TOMITAKA, A. & MATSUNAGA, K. (2001). Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem. Biophys. Res. Commun., 285, 1250-1252.
14. EVANS, A.R., NICOL, G.D. & VASKO, M.R. (1996). Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons. Brain. Res., 712, 265-273.
15. FACCHINETTI, F., DEL GIUDICE, E., FUREGATO, S., PASSAROTTO, M. & LEON, A. (2003). Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lipopolysaccharide. Glia, 41, 161-168.
16. FACCI, L., DAL TOSO, R., ROMANELLO, S., BURIANI, A., SKAPER, S.D. & LEON, A. (1995). Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U.S.A., 92, 3376-3380.
17. FANG, L., WU, J., LIN, Q. & WILLIS, W.D. (2002). Calcium-calmodulin- dependent protein kinase II contributes to spinal cord central sensitization. J. Neurosci., 22, 4196-4204.
18. FERREIRA, S.H. (1993). The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs, 46 (Suppl 1), 1-9.
19. FOX, A., KESINGLAND, A., GENTRY, C., MCNAIR, K., PATEL, S., URBAN, L. & JAMES, I. (2001). The role of central and peripheral cannabinoid 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
20. GALIEGUE, S., MARY, S., MARCHAND, J., DUSSOSSOY, D., CARRIERE, D., CARAYON, P., BOUABOULA, M., SHIRE, D., LE FUR, G. & CASELLAS, P. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 232, 54-61.
21. GARCIA-NICAS, E., LAIRD, J.M. & CERVERO, F. (2001). Vasodilatation in hyperalgesic rat skin evoked by stimulation of afferent A beta-fibers: further evidence for a role of dorsal root reflexes in allodynia. Pain, 94, 283-291.
22. GUNTHORPE, M.J., RAMI, H.K., JERMAN, J.C., SMART, D., GILL, C.H., SOFFIN, E.M., LUIS HANNAN, S., LAPPIN, S.C., EGERTON, J., SMITH, G.D., WORBY, A., HOWETT, L., OWEN, D., NASIR, S., DAVIES, C.H., THOMPSON, M., WYMAN, P.A., RANDALL, A.D. & DAVIS, J.B. (2004). Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology, 46, 133-149.
23. HERZBERG, U., ELIAV, E., BENNETT, G.J. & KOPIN, I.J. (1997). The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett., 221, 157-160.
24. HIMMEL, H.M., MEYER ZU HERINGDORF, D., GRAF, E., DOBREV, D., KORTNER, A., SCHULER, S., JAKOBS, K.H. & RAVENS, U. (2000). Evidence for Edg-3 receptor-mediated activation of I (KACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. Mol. Pharmacol., 58, 449-454.
25. HUANG, S.M., BISOGNO, T., TREVISANI, M., AL-HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A., 99, 8400-8405.
26. IBRAHIM, M.M., DENG, H., ZVONOK, A., COCKAYNE, D.A., KWAN, J., MATA, H.P., VANDERAH, T.W., LAI, J., PORRECA, F., MAKRIYANNIS, A. & MALAN JR, T.P. (2003). Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U.S.A., 100, 10529-10533.
27. INOUE, K., KOIZUMI, S., FUZIWARA, S., DENDA, S. & DENDA, M. (2002). Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem. Biophys. Res. Commun., 291, 124-129.
28. JENNINGS, E.A., VAUGHAN, C.W. & CHRISTIE, M.J. (2001). Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. J. Physiol., 534, 805-812.
29. JENNINGS, E.A., VAUGHAN, C.W., ROBERTS, L.A. & CHRISTIE, M.J. (2003). The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J. Physiol., 548, 121-129.
30. JOHANEK, L.M., HEITMILLER, D.R., TURNER, M., NADER, N., HODGES, J. & SIMONE, D.A. (2001). Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain, 93, 303-315.
31. JORDT, S.E., BAUTISTA, D.M., CHUANG, H.H., MCKEMY, D.D., ZYGMUNT, P.M., HOGESTATT, E.D., MENG, I.D. & JULIUS, D. (2004). Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature, 427, 260-265.
32. KHANOLKAR, A.D., PALMER, S.L. & MAKRIYANNIS, A. (2000). Molecular probes for the cannabinoid receptors. Chem. Phys. Lipids, 108, 37-52.
33. 2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience, 115, 613-625.
34. KIM, H.T., PARK, S.K., LEE, S.E., CHUNG, J.M. & LEE, D.H. (2001). Non-noxious A fiber afferent input enhances capsaicin-induced mechanical hyperalgesia in the rat. Pain, 94, 169-175.
35. KLEIN, T.W., NEWTON, C.A. & FRIEDMAN, H. (2001). Cannabinoids and the immune system. Pain. Res. Manage., 6, 95-101.
36. LAWSON, S.N., PERRY, M.J., PRABHAKAR, E. & MCCARTHY, P.W. (1993). Primary sensory neurones: neurofilament, neuropeptides, and conduction velocity. Brain. Res. Bull., 30, 239-243.
37. MACCARRONE, M., DI RIENZO, M., BATTISTA, N., GASPERI, V., ROSSI, A. & FINAZZI-AGRO, A. (2003). The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activating protein-1 and transglutaminase. J. Biol Chem., 278, 33896-33903.
38. MAGERL, W., WILK, S.H. & TREEDE, R.D. (1998). Secondary hyperalgesia and perceptual wind-up following intradermal injection of capsaicin in humans. Pain, 74, 257-268.
39. MARTIN, W.J., COFFIN, P.O., ATTIAS, E., BALINSKY, M., TSOU, K. & WALKER, J.M. (1999a). Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain. Res., 822, 237-242.
40. MARTIN, W.J., LOO, C.M. & BASBAUM, A.I. (1999b). Spinal Cannabinoids are anti-allodynic in rats with persistent inflammation. Pain, 82, 199-205.
41. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
42. MATTHEWS, E.A. & DICKENSON, A.H. (2001). Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain, 92, 235-246.
43. MCCARTHY, P.W. & LAWSON, S.N. (1990). Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity. Neuroscience, 34, 623-632.
44. MOLDERINGS, G.J., BONISCH, H., HAMMERMANN, R., GOTHERT, M. & BRUSS, M. (2002). Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int., 40, 157-167.
45. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
46. MURAKAMI, M., FLEISCHMANN, B., DE FELIPE, C., FREICHEL, M., TROST, C., LUDWIG, A., WISSENBACH, U., SCHWEGLER, H., HOFMANN, F., HESCHELER, J., FLOCKERZI, V. & CAVALIE, A. (2002). Pain perception in mice lacking the beta3 subunit of voltage-activated calcium channels. J. Biol. Chem., 277, 40342-40351.
47. NACKLEY, A.G., SUPLITA II, R.L. & HOHMANN, A.G. (2003). A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience, 117, 659-670.
48. PALMER, S.L., THAKUR, G.A. & MAKRIYANNIS, A. (2002). Cannabinergic ligands. Chem. Phys. Lipids, 121, 3-19.
49. PRICE, T.J., HELESIC, G., PARGHI, D., HARGREAVES, K.M. & FLORES, C.M. (2003). The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience, 120, 155-162.
50. PRICE, T.J., PATWARDHAN, A., AKOPIAN, A.N., HARGREAVES, K.M. & FLORES, C.M. (2004). Modulation of trigeminal sensor, neuron activity by the dual cannabinoid-vanilloid agonists anandamide. N-anachidonoyl-dopamine and anachidonyl-2-chloroethylamide. Br. J. Pharmacol., Mar 8 (E pub).
51. PUFFENBARGER, R.A., BOOTHE, A.C. & CABRAL, G.A. (2000). Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia, 29, 58-69.
52. SANG, C.N., GRACELY, R.H., MAX, M.B. & BENNETT, G.J. (1996). Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism. Anesthesiology, 85, 491-496.
53. SHEN, M. & THAYER, S.A. (1998). The cannabinoid agonist Win 55, 212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res., 783, 77-84.
54. SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) Br. J. Pharmacol., 129, 227-230.
55. SOUTHALL, M.D., LI, T., GHARIBOVA, L.S., PEI, Y., NICOL, G.D. & TRAVERS, J.B. (2003). Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther., 304, 217-222.
56. TODOROVIC, S.M., JEVTOVIC-TODOROVIC, V., MEYENBURG, A., MENNERICK, S., PEREZ-REYES, E., ROMANO, C., OLNEY, J.W. & ZORUMSKI, C.F. (2001). Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron, 31, 75-85.
57. WATANABE, H., VRIENS, J., PRENEM, J., DROOGMANS, G., VOETS, T. & NILIUS, B. (2003). Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature, 424, 434-438.
58. WATKINS, L.R., MILLIGAN, E.D. & MAIER, S.F. (2003). Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol., 521, 1-21.
59. YAMAGUCHI, F., TOKUDA, M., HATASE, O. & BRENNER, S. (1996). Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9. Biochem. Biophys. Res. Commun., 227, 608-614.
60. ZYGMUNT, P.M., ANDERSSON. D.A. & HOGESTATT, E.D. (2002). Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. J. Neurosci., 22, 4720-4727.
61. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.